Lawrence A. Kenyon

2017

In 2017, Lawrence A. Kenyon earned a total compensation of $595K as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 63% decrease compared to previous year.

Compensation breakdown

Bonus$100,000
Salary$350,000
Stock Awards$128,065
Other$16,940
Total$595,005

Kenyon received $350K in salary, accounting for 59% of the total pay in 2017.

Kenyon also received $100K in bonus, $128.1K in stock awards and $16.9K in other compensation.

Rankings

In 2017, Lawrence A. Kenyon's compensation ranked 11,235th out of 14,666 executives tracked by ExecPay. In other words, Kenyon earned more than 23.4% of executives.

ClassificationRankingPercentile
All
11,235
out of 14,666
23rd
Division
Manufacturing
4,400
out of 5,768
24th
Major group
Chemicals And Allied Products
1,598
out of 2,074
23rd
Industry group
Drugs
1,316
out of 1,730
24th
Industry
Biological Products, Except Diagnostic Substances
234
out of 316
26th
Source: SEC filing on August 17, 2018.

Kenyon's colleagues

We found two more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2017.

2017

Pankaj Mohan

Outlook Therapeutics

Chief Executive Officer

2017

Kenneth Bahrt

Outlook Therapeutics

Chief Medical Officer

News

You may also like